Shay Capital »

Arrowhead Pharmaceuticals shares owned by Shay Capital

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Shay Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 44k 81.51

More positions owned by Shay Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Take-Two Interactive Software (TTWO)
Ftai Aviation SHS (FTAI)
Purecycle Technologies (PCT)
Corecivic (CXW)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Baidu Spon Adr Rep A (BIDU)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Celsius Hldgs Com New (CELH)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Honeywell International (HON)
Golar Lng SHS (GLNG)
Papa John's Int'l (PZZA)

View all positions for Shay Capital

Top funds holding Arrowhead Pharmaceuticals

BlackRock
venBio Select Advisor
FMR
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Norges Bank Investment Management
Invesco
Geode Capital Management
Fred Alger Management
Baker Bros. Advisors
Susquehanna International
Siren
Vestal Point Capital
Henderson Group

View all funds holding Arrowhead Pharmaceuticals